| Serial Number | 79322618 |
| Word Mark | C |
| Filing Date | Friday, April 2, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 2, 2022 |
| Registration Number | 6805688 |
| Registration Date | Tuesday, August 2, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 17, 2022 |
| Description of Mark | The mark consists a hexagon shape consisting on the left side of a letter "C" in pantone cool gray 4 C and on the right side of the stylized representation of an anchor formed by a circle and a right pointing arrow in fuchsia pantone 227 C. |
| Goods and Services | Pharmaceuticals for the treatment of diseases of the respiratory system, central nervous system [CNS], the metabolic system, the cardio-vascular system, the musculo-skeletal system, immune system, gastro-intestinal system, endocrine system, or caused by bacteria; Pharmaceuticals for the treatment of autoimmune disorders, viral diseases, skin diseases; pharmaceuticals and natural remedies for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; pharmaceutical compositions for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; chemico-pharmaceutical preparations for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicines for human purposes for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicinal healthcare preparations for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicinal preparations and substances for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; biotechnological preparations for medical use for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; stem cells for medical purposes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; medicinal infusions for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; medicated compresses; preparations for detecting genetic predispositions for medical purposes; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the prevention of diseases of the cardio-vascular system; pharmaceutical preparations for the treatment of diseases of the musculo-skeletal system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the treatment of disorders caused by bacteria; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations for ophthalmological use; pharmaceutical products for ophthalmological use; medicated plasters; transdermal patches for the treatment of diseases of the musculo-skeletal system; transdermal patches for medical treatment of the musculo-skeletal system diseases; liquid vitamin supplements; nutritional supplements; nutraceutical preparations for therapeutic or medical purposes for the treatment cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; nutraceuticals for use as a dietary supplement; vitamin preparations in the nature of food supplements; dietary supplements consisting of vitamins; nutraceuticals for therapeutic purposes for the treatment of cardiovascular disorders, respiratory diseases, cardiopulmonary, neurological, gastrointestinal related diseases and disorders; enzyme dietary supplements; vitamin and mineral supplements; disinfectants and antiseptics; viral vaccines |
| Pseudo Mark | CHIESI |
| Indication of Colors claimed | The color(s) gray: pantone cool gray 4 c and fuchsia: pantone 227 c is/are claimed as a feature of the mark. |
| Goods and Services | Promotional and advertising services; advertising services relating to pharmaceutical products; advertising services to promote public awareness of medical issues; advertising services to promote public awareness of medical conditions; advertising services relating to cosmetics; providing consumer product information relating to cosmetics; retail store services in relation to dietetic preparations; retail store services in relation to pharmaceutical preparations; online retail store services in relation to cosmetics; retail store services in relation to medical instruments; retail store services in relation to medical apparatus; retail store services for a pharmaceutical, veterinary and sanitary preparations and medical supplies |
| Goods and Services | medical apparatus and instruments for treating cardiovascular disease, for treating osteoarthritis, for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; apparatus for administering pharmaceuticals, namely, medical devices for accessing subcutaneous structures of the human body; apparatus for administering drugs by inhalation sold empty; medical ventilators; oxygen inhalators for therapeutic purposes sold empty; infusion pumps to deliver medication; respiratory therapy instruments, namely, sterile disposable oxygen humidifiers and nebulizers for respiratory therapy sold pre-filled with water; medical apparatus for assisting breathing, namely, portable devices used for breathing exercises and for respiratory muscle training; portable nebulisers for medical purposes; ventilator breathing apparatus for artificial respiration; medical apparatus for the treatment of respiratory conditions, namely, infusion and injection devices for delivering pharmaceuticals and solutions, oxygen inhalators, infusion pumps, portable nebulisers for medical purposes, all sold emptymedical apparatus for the treatment of respiratory conditions, namely, infusion and injection devices for delivering pharmaceuticals and solutions, oxygen inhalators, infusion pumps, portable nebulisers for medical purposes, all sold empty; respiratory masks for medical purposes; inhalers for medical use, sold empty; nebulizers for respiration therapy; respirators for artificial respiration for medical purposes; apparatus for the alleviation of breathing difficulties, namely, infusion and injection devices; masks and equipment for artificial respiration; oxygenators for medical use; medical apparatus for facilitating the inhalation of pharmaceutical preparations, sold empty; vaporizers for the treatment of upper respiratory conditions; oxygen inhalers for medical use sold empty; diagnostic, examination and monitoring equipment, namely, equipment for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; surgical ophthalmic instruments; massage apparatus; dummies for babies; catheters for medical use; apparatus for the regeneration of stem cells for medical purposes; implantable subcutaneous drug delivery devices; prosthetics, namely, ligaments and tissues for vascular use and artificial implant; artificial limbs; orthopedic articles, namely, devices used in orthopedic transplant and/or implant surgery; orthopedic joint implants made of artificial materials; sphygmotensiometers; equipment for diagnosis, examinations and monitoring, namely, equipment for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events |
| Goods and Services | Scientific and technology services, namely, pharmaceutical drug development services; technological research services in the field of pharmaceutical research and development; scientific research in the field of pharmacy; scientific research relating to biology; scientific research relating to genetics; scientific research and industrial research in the field of pharmaceutical research and development; scientific research and analysis, namely, pharmaceutical research and development; scientific and technological services relating to pharmaceutical drug and nutritional supplements development; medical and pharmacological research services; providing scientific information in the field of medical disorders and their treatment; development of pharmaceutical preparations and medicines; research and development in the pharmaceutical and biotechnology fields; bacteriological research and analysis; biological research and analysis; chemical research and analysis services; clinical research, namely, conducting clinical trials for others; biological research, clinical research in the field of respiratory science and medicine and medical research; industrial analysis and research services in the field of pharmaceutical research; stem cell research; scientific services relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 19, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 19, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 19, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 19, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CHIESI FARMACEUTICI S.P.A. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | IT |
| Party Name | CHIESI FARMACEUTICI S.P.A. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | IT |
| Party Name | CHIESI FARMACEUTICI S.P.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | IT |
| Event Date | Event Description |
| Thursday, November 17, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, November 16, 2022 | FINAL DISPOSITION PROCESSED |
| Wednesday, November 2, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, August 2, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 2, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 17, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 17, 2022 | PUBLISHED FOR OPPOSITION |
| Monday, May 16, 2022 | NOTIFICATION PROCESSED BY IB |
| Wednesday, April 27, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 27, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, April 27, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, April 14, 2022 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, April 12, 2022 | ASSIGNED TO LIE |
| Monday, April 11, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, April 11, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Monday, April 11, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, April 11, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Monday, April 11, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, March 17, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, March 16, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 16, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 10, 2022 | REFUSAL PROCESSED BY IB |
| Wednesday, December 22, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, December 22, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, November 19, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, November 18, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 17, 2021 | ASSIGNED TO EXAMINER |
| Saturday, October 23, 2021 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, October 19, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, October 14, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |